Cargando…
Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
Most therapeutic agents are designed to target a molecule or pathway without consideration of the mechanisms involved in the physiological turnover or removal of that target. In light of this and in particular for Alzheimer’s disease, a number of therapeutic interventions are presently being develop...
Autores principales: | Morrone, Christopher D., Liu, Mingzhe, Black, Sandra E., McLaurin, JoAnne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419721/ https://www.ncbi.nlm.nih.gov/pubmed/25999850 http://dx.doi.org/10.3389/fnagi.2015.00064 |
Ejemplares similares
-
Potential Role of Venular Amyloid in Alzheimer’s Disease Pathogenesis
por: Morrone, Christopher D., et al.
Publicado: (2020) -
Editorial: Intramural Vascular Cells: Key Therapeutic Targets for Vascular Cognitive Impairment
por: Saito, Satoshi, et al.
Publicado: (2020) -
Compromised Cortical-Hippocampal Network Function From Transient Hypertension: Linking Mid-Life Hypertension to Late Life Dementia Risk
por: Lai, Aaron Y., et al.
Publicado: (2022) -
Regional differences in Alzheimer’s disease pathology confound behavioural rescue after amyloid-β attenuation
por: Morrone, Christopher D, et al.
Publicado: (2020) -
Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease
por: Morrone, Christopher Daniel, et al.
Publicado: (2022)